Across TCGA pan-cancer cohorts, MIR1276 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1276’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR1276 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR1276 is over-expressed in tumor, although a few such as STAD and KICH show the opposite, repressed pattern.

STAD, CHOL, and KICH are the cancer types where MIR1276 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1276 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	III,IV	−1.255	.033	1	view →
CHOL	All	All	+0.607	.039	1	view →
KICH	Female	All	−0.339	.035	1	view →
LUSC	All	All	+0.236	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR1276 RNA expression & survival · all MIR1276 data types